ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Norse Atlantic ASA (QX)

Norse Atlantic ASA (QX) (NRSAF)

0.35
0.00
(0.00%)
Closed January 05 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.35
Bid
0.044
Ask
0.495
Volume
-
0.00 Day's Range 0.00
0.138 52 Week Range 1.21
Market Cap
Previous Close
0.35
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
80,307
Shares Outstanding
266,084,316
Dividend Yield
-
PE Ratio
-0.55
Earnings Per Share (EPS)
-0.63
Revenue
439.44M
Net Profit
-168.75M

About Norse Atlantic ASA (QX)

Sector
Air Transport, Scheduled
Industry
Air Transport, Scheduled
Headquarters
Oslo, Nor
Founded
-
Norse Atlantic ASA (QX) is listed in the Air Transport, Scheduled sector of the OTCMarkets with ticker NRSAF. The last closing price for Norse Atlantic ASA (QX) was $0.35. Over the last year, Norse Atlantic ASA (QX) shares have traded in a share price range of $ 0.138 to $ 1.21.

Norse Atlantic ASA (QX) currently has 266,084,316 shares outstanding. The market capitalization of Norse Atlantic ASA (QX) is $93.13 million. Norse Atlantic ASA (QX) has a price to earnings ratio (PE ratio) of -0.55.

NRSAF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.037612.03585147250.31240.350.312435250.35CS
40.0257.692307692310.3250.350.312448810.34162612CS
120.192121.5189873420.1580.35390.138803070.32135917CS
26-0.0235-6.291834002680.37350.4020.138387490.31926629CS
52-0.86-71.07438016531.211.210.138269700.46688778CS
156-6.3108-94.74537593086.660880.138337901.2696154CS
260-7.73-95.66831683178.088.080.138334191.27066979CS

NRSAF - Frequently Asked Questions (FAQ)

What is the current Norse Atlantic ASA (QX) share price?
The current share price of Norse Atlantic ASA (QX) is $ 0.35
How many Norse Atlantic ASA (QX) shares are in issue?
Norse Atlantic ASA (QX) has 266,084,316 shares in issue
What is the market cap of Norse Atlantic ASA (QX)?
The market capitalisation of Norse Atlantic ASA (QX) is USD 93.13M
What is the 1 year trading range for Norse Atlantic ASA (QX) share price?
Norse Atlantic ASA (QX) has traded in the range of $ 0.138 to $ 1.21 during the past year
What is the PE ratio of Norse Atlantic ASA (QX)?
The price to earnings ratio of Norse Atlantic ASA (QX) is -0.55
What is the cash to sales ratio of Norse Atlantic ASA (QX)?
The cash to sales ratio of Norse Atlantic ASA (QX) is 0.21
What is the reporting currency for Norse Atlantic ASA (QX)?
Norse Atlantic ASA (QX) reports financial results in USD
What is the latest annual turnover for Norse Atlantic ASA (QX)?
The latest annual turnover of Norse Atlantic ASA (QX) is USD 439.44M
What is the latest annual profit for Norse Atlantic ASA (QX)?
The latest annual profit of Norse Atlantic ASA (QX) is USD -168.75M
What is the registered address of Norse Atlantic ASA (QX)?
The registered address for Norse Atlantic ASA (QX) is SANDVIGVEIEN 19, KOLBJ��RNSVIK, OSLO, 4816
What is the Norse Atlantic ASA (QX) website address?
The website address for Norse Atlantic ASA (QX) is www.flynorse.com
Which industry sector does Norse Atlantic ASA (QX) operate in?
Norse Atlantic ASA (QX) operates in the AIR TRANSPORT, SCHEDULED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGIOQEdgio Inc (CE)
$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
$ 0.00125
(-10.71%)
169.44M

Discussion

View Full Feed
devil dog 96 devil dog 96 3 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 3 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 7 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 7 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 27 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 30 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 31 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 31 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 32 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 33 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 34 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 35 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 36 minutes ago
Probably
AVXL
HokieHead HokieHead 38 minutes ago
Wrong..
TWOH
HokieHead HokieHead 39 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 40 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 42 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 42 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 43 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 43 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 44 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 45 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 47 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL